H2OPTX
Company

Last deal

$2.4M

Amount

Series A

Stage

01.09.2015

Date

1

all rounds

$2.4M

Total amount

General

About Company
H2OPTX offers 3D chemical imaging solutions for solid dosage formulations.

Industry

Sector :

Subsector :

founded date

01.11.2012

Number of employees

Company Type

For Profit

Last funding type

Series A

IPO status

Private

Description

The Silicon Valley-based company provides chemical and biologics analysis and monitoring services to the Life Sciences industry and research institutions, helping to enhance R&D and production performance. H2Optx’s mPAT™ LAB™ system is an automated scanning solution that combines various analytical methods, including Raman spectroscopy, UV spectroscopy, visible light spectroscopy, microscopy, high-resolution optical imaging, X-Y-Z surface scanning, and 3D imaging. The technology is designed to provide unprecedented microstructural detail in chemical and biological analysis, making it ideal for designing, fabricating, testing, and selling spectrometers. H2Optx has a growing customer base of both repeat and new Fortune 500 companies, with its products logging thousands of hours of use.
Contacts